MV targets tumor cells through various receptors, including lymphocyte activation molecule 150 (CD150), lymphocyte activation molecule 46 (CD46), and Nectin cell adhesion molecule 4 (NECTIN-4). The gene discussed is CD46; the disease is neoplasm.